35900-16-4Relevant academic research and scientific papers
USE OF PROSTAGLANDIN E1 METHYL ESTER IN PREPARING VASODILATOR DRUG
-
Paragraph 0019-0021, (2021/10/07)
Provided in the present invention is a use of prostaglandin E1 methyl ester in preparing a vasodilator drug. The structural formula of the prostaglandin E1 methyl ester is represented by formula (I) The vasodilator drug is a drug used to treat the following diseases: a microcirculatory disorder, coronary heart disease, angina, heart failure, pulmonary heart disease, cerebral infarction, amniotic fluid embolism, or scleroderma.
A prostaglandin E1 methyl ester freeze dried preparation for injection and its preparation and use (by machine translation)
-
Paragraph 0058-0063, (2019/03/23)
The present invention provides a prostaglandin E1 methyl ester freeze dried preparation for injection and preparation and application. The freeze-dried preparation comprises the following parts by weight ingredient: prostaglandin E1 methyl ester 0.1 - 10 parts, oil for injection 500 - 4000 parts, emulsifier 500 - 2000 parts, emulsifier 0 - 10 parts, lyophilized vaccine 5000 - 50000 parts, and glycerin 200 - 1500 parts. The invention prostaglandin E1 methyl ester freeze-dried agent has stimulate the blood vessel small, good stability of the medicine, and compared with similar prostaglandin E1 product just excellent pharmaceutical activity and the therapeutic effect. (by machine translation)
Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
-
, (2008/06/13)
The invention describes prostaglandin E1 derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration.
